Artificial Skin Helps with Rare Blister Disease

Article

WASHINGTON, DC-Children afflicted with a rare genetic disease may be helped with a new artificial skin.

The Food and Drug Administration (FDA) recently approved the skin. Children who have epidermolysis bullosa have severe blisters that can scar and leave the fingers melded together like a mitten. Their fingers must be separated surgically, wrapped in non-sticky bandages and healed with skin grafts. The healing process takes extensive amounts of time, leaving the door open for infection.

New York-based Ortec International Inc., wants to change this process with a composite cultured skin made from living skin cells and the foreskins from circumcised newborn baby boys. The new artificial skin is aimed at those who are severely affected by the disease. There are 4,000 people diagnosed per year with EB.

Australian surgeons using the new skin found it helped speed up the healing process, therefore, preventing infection.

Information from www.washingtonpost.com

Newsletter

Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.

Recent Videos
 Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio
In a recent discussion with Infection Control Today® (ICT®), study authors Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio, shared their insights on how the project evolved and what the findings mean for the future.
 Futuristic UV Sanitizer with Sleek Design on a white background.  (Adobe Stock 1375983522 by Napa)